engadget podcast: why did silicon valley bank fail so hard?

Elon Musk and Neuralink have recently made headlines regarding the development of a brain-computer interface, with plans to begin human trials in 2020. Unfortunately, the FDA has denied them permission to move forward with the trials, citing safety concerns. This marks the first time that Neuralink’s technology has been tested on humans – it had previously been tested on pigs.

Neuralink is a startup created by Musk and his team, which aims to create a computer-brain interface to allow people to control computers with their thoughts. It would do this by implanting small electrodes into the brain, which would then detect signals and transmit them to a device. The company has already successfully tested its technology on pigs, with the animals being able to control computer games with their minds.

The FDA's decision to not permit human trials was made due to safety concerns. Specifically, they were worried about potential effects on patients and the potential for unintended consequences. They also raised questions about potential animal testing data, as well as other data collected from the device.

Despite the setback, Musk and Neuralink remain committed to their vision. They still plan to move forward with their ambitions, although the timeline for success is uncertain. In the meantime, the company will continue to develop and refine its technology, and hopefully find a way to convince the FDA to change their position and approve human trials.

Read more here: External Link